Dr. Rahul Seth, MD

Dr. Seth practices at Golden State Dermatopathology in Walnut Creek, California.

Dr. Seth's NPI, 1073784682, was assigned on March 22, 2008. Dr. Seth graduated from University of Rochester Medical Center in 2006. Dr. Seth holds California license A120806.

Dr. Seth's primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Dr. Seth's primary practice is Golden State Dermatopathology in Walnut Creek, California. Dr. Seth is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Seth to 4 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Seth's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seth practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery within the head and neck is Dr. Seth's primary specialty in the NPI Registry, under taxonomy code 207YX0007X. Dr. Seth is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Seth's licenses on file in 2 states: California and Ohio.

CMS data shows 42 Medicare services from Dr. Seth across 2 procedure codes in 2024, all of them office visits, for 79 Medicare patients. Medicare paid $2,815 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Seth in 2024. The largest group is 65 to 74, with 35 patients. 71% of them have high cholesterol, and 61% have high blood pressure. 18% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Seth's median patient age at 39, with 54% women.

In 2024, Dr. Seth wrote 79 Medicare Part D claims for 36 patients. 100% of them were for generic drugs. CMS names the drug for 53 of them, across 2 drugs with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Seth for performance year 2024, reported as part of a group. Dr. Seth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of melanoma (skin cancer) excision by Dr. Seth, more than 67% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Seth, published from 2007 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Face, Gender-Affirming Surgery and Bone Plates. Dr. Seth has published most often in Facial Plast Surg Aesthet Med. Dr. Seth's most frequent co-authors are Rahul Seth, DO, Philip Daniel Knott, MD and Suresh Mohan, MD.

Dmand AI links Dr. Seth to 1 clinical trial. Conditions studied include Seroma and Inflammation.

CMS Open Payments shows 65 general payments to Dr. Seth from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Abbvie Inc. paid the most, $16,237.

Dr. Seth graduated from University of Rochester Medical Center in 2006. Dr. Seth is a member of AOA, AAFPRS and NHS.

Dr. Seth is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.